Combination of Gatipotuzumab and Tomuzotuximab in Patients With Solid Tumors

Clinical trial NCT03360734 · COMPLETED

Trial details

NCT number: NCT03360734
Sponsor: Glycotope GmbH
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor, Adult

Start date: 2017-11-02
Primary completion: 2020-05-04
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.